Aladdin-1

4-(4-Methylpiperazin-1-yl)-4-oxobutanoic acid

2-Hydroxy-3,3-dimethylbutanoic acid

1-(1H-Indazol-1-yl)ethanone

CMP-5 is a potent, specific, and selective PRMT5 inhibitor, while displays no activity against PRMT1 , PRMT4 , and PRMT7 enzymes. CMP-5 selectively blocks S2Me-H4R3 by inhibiting PRMT5 methyltransferase activity on histone preparations.

CMP-5 is a potent, specific, and selective PRMT5 inhibitor, while displays no activity against PRMT1 , PRMT4 , and PRMT7 enzymes. CMP-5 selectively blocks S2Me-H4R3 by inhibiting PRMT5 methyltransferase activity on histone preparations.

Nrf2-IN-1 is an inhibitor of nuclear factor-erythroid 2-related factor 2 (Nrf2) . Nrf2-IN-1 is developed for the research of acute myeloid leukemia (AML)In VitroNrf2-IN-1 (Compound 4f) (10 μM) inhibits Nrf2 activation.

Nrf2-IN-1 is an inhibitor of nuclear factor-erythroid 2-related factor 2 (Nrf2) . Nrf2-IN-1 is developed for the research of acute myeloid leukemia (AML)In VitroNrf2-IN-1 (Compound 4f) (10 μM) inhibits Nrf2 activation.

Nrf2-IN-1 is an inhibitor of nuclear factor-erythroid 2-related factor 2 (Nrf2) . Nrf2-IN-1 is developed for the research of acute myeloid leukemia (AML)In VitroNrf2-IN-1 (Compound 4f) (10 μM) inhibits Nrf2 activation.

Methyl 5-hydroxypentanoate

2-Nonadecanone

Nortriptyline Hydrochloride

2-(Chloromethyl)-3-fluoropyridine hydrochloride